Veterinary Medicines

BIAVAC

Authorised
  • Infectious bursal disease virus, strain BIA Cj, Live
Download as PDF

Product identification

Medicine name:
BIAVAC
Active substance:
  • Infectious bursal disease virus, strain BIA Cj, Live
Target species:
  • Chicken
Route of administration:
  • Oral use
  • Ocular use

Product details

Active substance and strength:
  • Infectious bursal disease virus, strain BIA Cj, Live
    3.00
    log 10 50% embryo infective dose
    /
    0.05
    millilitre(s)
Pharmaceutical form:
This information is not available for this product.
Withdrawal period by route of administration:
  • Oral use
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
  • Ocular use
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD09
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Romania
Available in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
  • Pasteur Filiala Filipesti S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Pasteur Filiala Filipesti S.A.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 150507
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 23/05/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."